Abstracts - faqs.org

Abstracts

Health

Search abstracts:
Abstracts » Health

Time will be of the essence in treating Alzheimer disease

Article Abstract:

Study is presented to estimate the interactive effects of normal aging and presence of the apolipoprotein E (APOE*4) allele on cerebrospinal fluid (CSF) A(beta)42 concentration in adults with normal cognition across the life span. The goal is to sequence the genomes of families with and without Alzheimer disease and to seek polymorphisms in a small subset of genes that increase the chances of risk or are causal of disease.

Author: Lee, Virginia M.-Y., Clark, Chris, Peskind, Elaine R., Raskind, Murray, Ge Li, Shofer, Jane, Quinn, Joseph F., Kaye, Jaffrey A., Decarli, Charles, Schellenberg, Gerard D., Galasko, Douglas R.
Publisher: American Medical Association
Publication Name: JAMA, The Journal of the American Medical Association
Subject: Health
ISSN: 0098-7484
Year: 2006
Health aspects, Risk factors, Apolipoproteins, Disease/Disorder overview

User Contributions:

Comment about this article or add new information about this topic:

CAPTCHA

Killing pain, killing neurons?

Article Abstract:

Results from several placebo-controlled clinical treatment trials indicate that the nonsteroidal anti-inflammatory drugs (NSAIDs) fail to avoid the risk of developing Alzheimer disease. Moreover, one class of NSAIDs, the cyclooxygenase-2 (COX-2) inhibitors, is shown to cause side-effects including an increase in heart attacks and strokes in patients.

Author: Wyss-Coray, Tony
Publisher: Nature America, Inc.
Publication Name: Nature Medicine
Subject: Health
ISSN: 1078-8956
Year: 2005
United States, Usage, Complications and side effects, COX-2 inhibitors, Nonsteroidal anti-inflammatory drugs, Nonsteroidal anti-inflammatory agents

User Contributions:

Comment about this article or add new information about this topic:

CAPTCHA

Classification and prediction of clinical Alzheimer's diagnosis based on plasma signaling proteins

Article Abstract:

The article presents the importance of 18 plasma signaling proteins in classifying and predicting the correct diagnosis for Alzheimer's disease. Such tests are expected to lead to the development of better treatments and therapies.

Author: Tibshirani, Robert, Wyss-Coray, Tony, Jutel, Marek, Miller, Bruce L., Yesavage, Jerome A., Robinson, William H., Quinn, Joseph F., Galasko, Douglas R., Blennow, Kaj, Ray, Sandip, Britschgi, Markus, Herbert, Charles, Takeda-Uchimura, Yoshiko, Boxer, Adam, Friedman, Leah F., Karydas, Anna, Kaye, Jeffery A., Leszek, Jerzy, Minthon, Lennart, Rabinovici, Gil D., Sabbagh, Marwan, So, Yuen T., Sparks, D. Larry, Tabaton, Massimo, Tinklenberg, Jared
Publisher: Nature America, Inc.
Publication Name: Nature Medicine
Subject: Health
ISSN: 1078-8956
Year: 2007
Science & research, Research, Genetic aspects, Hematopoiesis, Plasma products

User Contributions:

Comment about this article or add new information about this topic:

CAPTCHA


Subjects list: Care and treatment, Alzheimer's disease
Similar abstracts:
  • Abstracts: The role of ACE inhibitor therapy in treating cardiovascular disease. Identifying and managing the complications of diabetes
  • Abstracts: Efficacy of pamidronate in reducing skeletal events in patients with advanced multiple myeloma. Lenalidomide plus dexamethasone for relapsed or refractory multiple myeloma
  • Abstracts: Involving patients in staff hand hygiene. Best practice in urinary catheterisation and catheter care
  • Abstracts: The effect of link nurses on hospital readmission rates. 'Cannabis can compound mental health problems'
  • Abstracts: Work relationships between agency and permanent staff. Halting death by indifference. It's all about the individual
This website is not affiliated with document authors or copyright owners. This page is provided for informational purposes only. Unintentional errors are possible.
Some parts © 2025 Advameg, Inc.